A novel coating on the catheter surface mimics the glycocalyx layer found on natural endothelial tissue surfaces in vessel walls. Laboratory tests of the DuraspanTM catheter have demonstrated an 87% reduction in platelet adhesion and thrombus accumulation compared to uncoated catheters.
According to Kyle Smith, DO, Vascular Access Center of Southwest Louisiana, “Thrombus accumulation is one of the leading causes of failure among long-term hemodialysis catheters. Initially, thrombus may cause reduced flow rates, significantly decreasing the efficiency of even the largest catheters. Ultimately, thrombus may have catastrophic effects to the patient as it may prevent use of the venous access site for permanent forms of dialysis. My experience with DuraspanTM thus far has shown excellent performance and patency.”
Studies have shown almost 30% of prevalent hemodialysis patients use catheters for vascular access. Catheter complications are a major cause of morbidity and mortality for hemodialysis patients and increase the burden on the health care system. Surface treated catheters have been developed to combat the three most common causes of catheter failure: infection, fibrin sheath formation and thrombus formation. Thrombotic reducing coatings reduce platelet adhesion, inhibit the inflammatory response, and reduce thrombus formation on coronary stents, ventricular assist devices, central venous catheters, and vascular grafts.
R4 is committed to improving dialysis patient catheter outcomes according to r4 Vascular’s President, Don Geer, “physicians have long thought that if one was able to make the catheter less recognizable as a foreign object in the body it could revolutionize catheter-based hemodialysis. Developing the catheter, r4 Vascular engineers utilized stealth coating technologies, approaching the thrombus problem by camouflaging the catheter in a biomimetic coating.” The catheter is available in either a 3.5cm tip stagger or a 7cm tip stagger version, providing reduced recirculation.R4 will be “launching” sales of the catheter at the S.I.R. (Society of Interventional Radiology) conference March 13th through March 18th in Tampa, FL.
The DuraspanTM hemodialysis catheter is part of r4 Vascular’s technologically-advanced portfolio of products for the vascular access marketplace. In 2009, r4 Vascular launched the Zeus™ Biomimetic Coated CT PICC which is the first non-valved PICC to receive FDA clearance for saline-only maintenance, the company also launched the Pherocious Apheresis catheter which is the first power-injectable, triple lumen Apheresis catheter.
r4 Vascular is a privately-held vascular access company driving innovation in vascular access medical technology. r4's passion is “uncomplicating” venous access, chemotherapy, and drug delivery, through product improvements that help catheters remain patent and effective, with reduced risk of complications.
 Dwyer A. Reducing Tunneled Hemodialysis Catheter Morbidity : Surface Treated Catheters-A Review. Seminars in Dialysis-Vol 21, No 6 (November-December) 2008. 542-546.
Don Geer | r4 Vascular
Novel PET tracer identifies most bacterial infections
06.10.2017 | Society of Nuclear Medicine and Molecular Imaging
Teleoperating robots with virtual reality
05.10.2017 | Massachusetts Institute of Technology, CSAIL
University of Maryland researchers contribute to historic detection of gravitational waves and light created by event
On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...
Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.
Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....
Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).
When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...
Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.
How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...
Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.
It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...
17.10.2017 | Event News
10.10.2017 | Event News
10.10.2017 | Event News
17.10.2017 | Life Sciences
17.10.2017 | Life Sciences
17.10.2017 | Earth Sciences